Publications by authors named "Marie Fasehun"
Allergy Asthma Proc
January 2024
Article Synopsis
- Hereditary angioedema (HAE) leads to unpredictable swelling episodes, and this study assesses the treatment burden linked to on-demand therapies by examining adverse drug reactions (ADRs) reported to the FDA.
- The analysis of the FAERS database from 2009 to 2022 focused on four FDA-approved HAE therapies, categorizing ADRs into 18 domains to identify trends in administration-site reactions.
- The findings indicated that plasma-derived C1-inhibitor (pdC1-INH) had the highest reports of injection-site issues, while recombinant C1-inhibitor (rhC1-INH) was unique for reporting access-site complications, suggesting consistency with clinical trial data on treatment side effects.
